Polyclonal Rabbit anti‑Human UBE1L2 / UBE1L2 Antibody (aa775‑825, IHC, WB) LS‑C148366
Polyclonal Rabbit anti‑Human UBE1L2 / UBE1L2 Antibody (aa775‑825, IHC, WB) LS‑C148366
Antibody:
UBE1L2 / UBE1L2 Rabbit anti-Human Polyclonal (aa775-825) Antibody
Application:
IHC, IHC-P, WB
Format:
Unconjugated, Unmodified
Overview
Antibody:
UBE1L2 / UBE1L2 Rabbit anti-Human Polyclonal (aa775-825) Antibody
Application:
IHC, IHC-P, WB
Format:
Unconjugated, Unmodified
Specifications
Description
UBE1L2 antibody LS-C148366 is an unconjugated rabbit polyclonal antibody to human UBE1L2 (UBE1L2) (aa775-825). Validated for IHC and WB.
Target
Human UBE1L2 / UBE1L2
Synonyms
UBA6 | FLJ10808 | Monocyte protein 4 | MOP-4 | Ubiquitin-activating enzyme 6 | E1-L2 | MOP4 | UBE1L2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
A portion of amino acids 775-825 of human UBE1L2/MOP-4.
Applications
- IHC
- IHC - Paraffin
- Western blot (0.5 - 2 µg/ml)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.05% Sodium Azide, 0.05% BSA
Storage
Store at 4°C for short term applications. For long term storage, aliquot and store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat, Bovine, Horse
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Reactivity:
Human
Range:
0.781-50 ng/ml
Reactivity:
Mouse
Range:
78.125-5000 pg/ml
Source:
Human
Tag:
Myc-DDK (Flag)
Reactivity:
Human
Range:
3.12-200 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/26/2024